Register entry
Chugai Pharmaceutical Co., Ltd.
- Registered sites
- 3
- Drug products
- 13
- Live patents
- 0
- Countries
- 1
- Base
- Japan
Authorisation
Registered operations
What the FDA has registered these sites to do. This is the regulatory record, not a marketing claim.
Analytical testingActive ingredient (API) manufactureFinished drug manufacture
Sites
Facilities
3| Site | Location | Operations | FEI |
|---|---|---|---|
| Chugai Pharma Manufacturing Co., Ltd | FujiedaJapan | Analytical testing, Finished drug manufacture | 3002806758 |
| Chugai Pharma Manufacturing Co., Ltd | Kita-kuJapan | Analytical testing, Active ingredient (API) manufacture, Finished drug manufacture | 3004109596 |
| Chugai Pharma Manufacturing Co., Ltd | UtsunomiyaJapan | Analytical testing, Active ingredient (API) manufacture, Finished drug manufacture | 3006942691 |
Catalogue
Marketed products
13Showing 13 of 13.
| Brand | Generic name | Form | Category |
|---|---|---|---|
| - | Alectinib Hydrochloride | CAPSULE | DRUG FOR FURTHER PROCESSING |
| - | Emicizumab | INJECTION, SOLUTION | DRUG FOR FURTHER PROCESSING |
| - | Emicizumab | INJECTION, SOLUTION | DRUG FOR FURTHER PROCESSING |
| - | Emicizumab | INJECTION, SOLUTION | DRUG FOR FURTHER PROCESSING |
| - | Emicizumab | INJECTION, SOLUTION | DRUG FOR FURTHER PROCESSING |
| - | Emicizumab | LIQUID | DRUG FOR FURTHER PROCESSING |
| - | Nemolizumab | LIQUID | DRUG FOR FURTHER PROCESSING |
| - | Satralizumab | INJECTION, SOLUTION | DRUG FOR FURTHER PROCESSING |
| - | Tocilizumab | LIQUID | DRUG FOR FURTHER PROCESSING |
| - | Tocilizumab | INJECTION, SOLUTION | DRUG FOR FURTHER PROCESSING |
| - | Tocilizumab | INJECTION, SOLUTION, CONCENTRATE | DRUG FOR FURTHER PROCESSING |
| - | Tocilizumab | INJECTION, SOLUTION, CONCENTRATE | DRUG FOR FURTHER PROCESSING |
| - | Tocilizumab | INJECTION, SOLUTION, CONCENTRATE | DRUG FOR FURTHER PROCESSING |
Provenance
Facility and operations data from the FDA Drug Establishments Current Registration Site. Product data from the openFDA National Drug Code Directory. Patent and exclusivity data from the FDA Orange Book. Shortage data from the FDA drug shortage database. Contact details the FDA publishes for registered establishments are deliberately not reproduced here. This entry is compiled from public records and has not been claimed by the company.